维普期刊资源整合服务平台（V6.5）

98篇 您的检索式：作者名="Biesma"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	An age-adapted approach for the use of D-dimers in the exclusion of deep venous thrombosis 显示文摘	Haas FJ Schutgens RE Biesma DH	2009	Am J Hematol2009，84，：	1
2	An age-adapted approach for the use of D-dimers in the exclusion of deep venous thrombosis显示文摘	Haas FJ Schutgens RE Biesma DH		0，，8：	1
3	An age-adapted approach for the use of D-dimer in the exclusion of deep venous thrombosis 显示文摘	Haas FJ Sehutqens RE Biesma DH	2009	Am J Hematol2009，84，8：	1
4	The effects of global health initiatives on country health systems:a review of the evidence from HIV/AIDS control显示文摘	Biesma R Brugha R Harmer A	2009	Health Policy and Planning2009，24，4：	1
5	Paclitaxel and carboplatin inthe treatment of small-cell lung cancer patients resistant to cyclop -hosphamide,doxorubicin,and etoposide:a non-cross-resistant sched -ule显示文摘	Groen HJ Fokkema E Biesma B	1999	J Clin Oncol1999，17，3：	1
6	Phase III, randomized, double-blind, placebo-controlled trial of gemcitabiue/cisplatin alone or with sorafenib for the first-line treatment of advanced, nonsquamous non- small-cell lung cancer 显示文摘	Paz-Ares L G Biesma B Heigener D	2012	J Clin Oncol2012，30，25：	1
7	Turning severe into moderate hemophilia by prophylaxis: are we reaching our goal? 显示文摘	Den Uijl I Biesma D Girobbee D	2013	Blood Transfus2013，11，3：	1
8	Dexamethasone downregulates the systemic cytokine response in patients with community-acquired pneumonia显示文摘	Remmelts HI-I Meijvis SC Biesma DH van Velzen-Blad H Voorn GP Grutters JC	2012	Clin Vaccine Immunol2012，19，9：	1
9	Hyperhomocysteinaemia as a cardiovascular risk factor: an update显示文摘	Van der Griend R Biesma DH Banga JD	2000	Neth J Meal2000，56，3：	1
10	Hyperhomocysteinaemia as a cardiovascular risk factor: an update显示文摘	Van-der-Griend R Biesma DH Banga JD	2000	Neth J Med2000，56，3：	1
11	Ambivalence of Primary Health Care Professionals towards the South African Guidelines for Hypertension and Diabetes显示文摘	Andre Daniels Regien Biesma Judith Otten	2002	SAM J2002，90，12：	1
12	Paclitaxel and carboplatin in the treatment of small-cell lung cancer patients resistant to cyclophosphamide, doxorubicin and etoposide: A non-cross-resistant schedule显示文摘	Groen H Fokkema E Biesma B	1999	J Clin Oncol1999，17，3：	1
13	Phase II study of induction chemotherapy in patients with stage IIIB NSCLC显示文摘	C Pitz A Brutel de la Riviere F van Beek N Schlosser P Hofman H Dik J Kersbergen B Biesma F Schramel	2000	Lung Cancer2000，，1：	1
14	Postmethionine-load homocysteine determination forthe diagnosis hyperhomocysteinaemia and efficacy ofhomocysteine lowering treatment regimens 显示文摘	van der Griend R Biesma DH Banga JD	2002	VaseMed2002，7，：	1
15	A randomized phaseⅡstudy comparing erlotinib versus erlotinib with alternating chemotherapy in relapsed nonsmall-cell lung cancer patients:the NVALT-10study显示文摘	Aerts JG Codrington H Lankheet NA Burgers S Biesma B Dingemans AM	2013	Ann Oncol2013，24，11：	1
16	Dexamethasone downregu- lates the systemic cytokine response in patients with community-ac- quired pneumonia 显示文摘	Remmelts HH Meijvis SC Biesma DI't	2012	Clin Vaccine Immunol2012，19，9：	1
17	The effects of global health initiatives on country health systems:a review of the evidence from HIV/AIDS control显示文摘	Biesma RG Brugha R Harmer A	2009	Health Policy Plan2009，24，4：	1
18	Paclitaxel and carboplatin in the treatment of small-cell lung cancer patients resistant to cyclophosphamide,doxorubicin, and etoposide: a non-cross-resistant schedule 显示文摘	Groen HJ Fokkema E Biesma B	1999	J Clin Oncnl1999，17，3：	1
19	Dexamethasone downregulates the systemic cytokine response in patients with com- munity-acquired pneumonia 显示文摘	Remmelts HH Meijvis SC Biesma DH	2012	Clin Vaccine Immunol2012，19，9：	1
20	Anaemia management with epoetin alfa in lung cancer patients in The Netherlands显示文摘	Biesma B van de Werf PR Melissant CF	2007	Lung Cancer2007，，：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示